biopharma

BOSTON, August 4, 2026 Rhythm Pharmaceuticals announced encouraging preliminary Phase 2 clinical trial results for RM-718, its investigational once-weekly...

North Chicago, Ill., July 29, 2026 AbbVie announced that the European Commission (EC) has approved RINVOQ® (upadacitinib) for the...

BOSTON, Mass. and TOKYO, Japan, July 28, 2026 CORE Biomedicine has entered into an exclusive global licensing agreement with...

GAITHERSBURG, Md., July 28, 2026 Altimmune, Inc. announced positive topline results from its Phase 2 RECLAIM clinical trial evaluating...

CHENGDU, China, July 27, 2026 Kelun-Biotech has announced that the Center for Drug Evaluation (CDE) of China’s National Medical...

CAMBRIDGE, UK, July 27, 2026 AstraZeneca has announced positive high-level results from the global Phase III CLARITY-Gastric01 trial, demonstrating...

PARIS, France, July 24, 2026 Sanofi announced that it has discontinued the clinical development of amlitelimab for moderate-to-severe atopic...

PARIS & LONDON, July 17, 2026 Aqemia, the biotechnology company pioneering physics-based generative artificial intelligence (AI) for drug discovery,...

DURHAM, N.C., July 8, 2026 GeneCentric has announced the launch of ExpressCT Rewind™, a retrospective fragmentomics analysis service designed...

TEL AVIV, Israel, and BURLINGTON, Mass., July 8, 2026 Chemomab Therapeutics and Scipher Medicine have entered into a definitive...